Dow Up 1.31% Nasdaq Up 2.40%

Dicerna Pharmaceuticals, Inc. (DRNA)

-NMS
9.42 0.07(0.74%) Oct 21, 4:00PM EDT
Prev Close:9.49
Open:9.56
Bid:0.01 x 100
Ask:17.50 x 100
1y Target Est:38.50
Beta:N/A
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:9.30 - 9.79
52wk Range:9.30 - 46.00
Volume:110,837
Avg Vol (3m):190,215
Market Cap:167.37M
P/E (ttm):N/A
EPS (ttm):-4.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for DRNA

Comparison

Symbol% ChgMkt Cap
DRNADown 0.74%167.37M
AMGN109.45B
BAYRY110.19B
TKMRN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.74
Quarterly EPS Est (Sep-14) :-0.63
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback